Intervention not reported
Cramp intensity (moderate or worse at 4 weeks) · pregnant women with leg cramps
The review found no eligible studies for this question.
1 finding from 1 review
Intervention not reported
Cramp intensity (moderate or worse at 4 weeks) · for effects on cramps, people (other than pregnant women) with muscle cramps (largely older adults); for adverse events, all populations
The intervention showed no clear difference in cramp intensity (moderate or worse at 4 weeks) (moderate certainty).
1 finding from 1 review
All‐cause short‐term mortality: at intensive care unit · adults with cardiogenic shock
It is very uncertain whether dopamine‐milrinone changes all‐cause short‐term mortality: at intensive care unit compared with dopamine‐dobutamine (very low certainty).
1 finding from 1 review
Physical health: pain intensity (VAS post‐treatment scores) · adults and children with hemophilia
1 finding from 1 review
Composite outcome: symptoms of leg cramps (intensity and frequency) Complete recovery: no leg cramps after treatment · treating leg cramps in pregnancy
It is very uncertain whether oral magnesium changes composite outcome: symptoms of leg cramps (intensity and frequency)… compared with placebo/no treatment (very low certainty).
1 finding from 1 review
Intensity of pain during treatment: mean total scale points The degree of pain was noted in the form, on a scale from 0 to 4 measured over 4 days and nights (0 = no pain, 1 = light pain, 2 = medium pain, 3=strong pain, 4=extreme pain) · treating leg cramps in pregnancy
1 finding from 1 review
At least 50% reduction in pain · treating leg cramps in pregnancy
It is very uncertain whether oral magnesium changes intensity of pain: 50% reduction in pain score 100‐mm visual… compared with placebo/no treatment (very low certainty).
1 finding from 1 review
Patient‐reported pain intensity or pain relief (VAS, NRS or categorical scale) · treating leg cramps in pregnancy
1 finding from 1 review
Composite outcome: symptoms of leg cramps (intensity and frequency) Partial improvement: decrease in intensity and frequency · treating leg cramps in pregnancy
It is very uncertain whether oral magnesium changes composite outcome: symptoms of leg cramps (intensity and frequency)… compared with placebo/no treatment (very low certainty).
1 finding from 1 review
Patient‐reported pain intensity or pain relief (VAS, NRS or categorical scale) · children (0 to 18 years)
1 finding from 1 review
Acute pain · children (0 to 18 years)
5 findings from 1 review
no estimate extracted
2 studies · 106 participants
Low
no estimate extracted
8 studies · 575 participants
Very low
no estimate extracted
3 studies · 187 participants
Low
Show 2 more findings
Patient‐reported pain intensity or pain relief (VAS, NRS or categorical scale) · children (0‐18 years)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Acute pain · children (0‐18 years)
The review found no eligible studies for this question.
5 findings from 1 review
no estimate extracted
Studies not reported
No studies found
no estimate extracted
Studies not reported
No studies found
no estimate extracted
Studies not reported
No studies found
Show 2 more findings
no estimate extracted
Studies not reported
No studies found
no estimate extracted
Studies not reported
No studies found
Acute pain · children (0 to 18 years)
The review found no eligible studies for this question.
5 findings from 1 review
Show 2 more findings
Patient‐reported pain intensity or pain relief (VAS, NRS or categorical scale) · children (0 to 18 years)
1 finding from 1 review
Intradialytic hypotension · people with CKD requiring dialysis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intradialytic hypotension · people with CKD requiring dialysis
Dihydropyridine calcium channel blockers showed no clear difference in intradialytic hypotension compared with placebo/control (low certainty).
1 finding from 1 review
Serious adverse events and liver‐related morbidity: incidence of congestive hypertensive gastropathy · primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis
It is very uncertain whether sclerotherapy changes serious adverse events and liver‐related morbidity: incidence of… compared with no intervention (very low certainty).
1 finding from 1 review
Hypotension (ARB; withdrawn from study) · heart failure with chronic kidney disease
It is very uncertain whether CHRONIC: ACEi or ARB changes hypotension (ARB; withdrawn from study) compared with placebo (very low certainty).
1 finding from 1 review
Hypotension · heart failure with chronic kidney disease
It is very uncertain whether CHRONIC: Beta‐blockers changes hypotension compared with placebo (very low certainty).
1 finding from 1 review